The activity of choline-phosphate cytidylyltransferase is increased by glucocorticoids in late gestation fetal lung in association with increased phosphatidlyleholine biosynthesis. Previous indirect data had suggested that the stimulator~ effect of the hormone was due to activation of existing enzyme rather than synthesis of new cytidylyltransferase protein.
The activity of choline-phosphate cytidylyltransferase is increased by glucocorticoids in late gestation fetal lung in association with increased phosphatidlyleholine biosynthesis. Previous indirect data had suggested that the stimulator~ effect of the hormone was due to activation of existing enzyme rather than synthesis of new cytidylyltransferase protein.
Using a rabbit antibody raised against purified rat liver choline-phosphate cytidylyltransferase, we have now quantitated the amount of the enzyme in fetal rat lung explants cultured with and without dexamethasone. Our results show that the hormone increased the activity of the enzyme but not the amount of cytidylyltransferase protein. Thus the stimulatory effect of dexamethasone on cytidyW.yltransferase is due to activation of existing enzyme rather than induction of enzyme synthesis.
Choline-phosphate cytidylyltransferase (cytidylyltransferase; EC 2.7.7.i5) is an important regulatory enzyme [1] [2] [3] . Its activity has been 2how-n to be increased in association with increased de novo phosphatidylcholine biosynthesis in several systems [1] [2] [3] . The developing fetal lung is a useful model system in which to study the regulation of phosphatidyicholine biosynthesis. The alveolar surface of the lung is lined with a phosphatidylcholine-rich material, pulmonary surfactant, which is essential for normal lung function [4] . Towards the end of gestation, as the fetal lung matures in preparation for air breathing, there is a surge in surfactant as well as phosphatidylcholine biosynthesis [3, 5] . Fetal lung maturation, surfactant production and phosphatidylcholine biosynthesis are all enhanced by glucocorticoids, estrogen and thyroid hormone [3] [4] [5] . The hormone-induced increases in phosphatidylcholine biosynthesis are accompanied by increases in the activity of cytidylyltransferase [3] .
When s,.lbcellular fractionation is carried out, eytidylyltransferase activity is found in both the cytosoI and endoplasmic reticulum [1] [2] [3] . There is evidence from a number of systems that the membrane-bound Correspondence: S.A. Roone~, Yale Dept. of Pediatrics, P.O. Box 3333, New Haven, CT 06510, U.S.A. enzyme is the active form and that the increase in activity which accompanies the increase in phosphatidyicholine synthesis is due to enzyme transfer from cytosol to endoplasmic reticulurn [1, 6, 7] . Subcellular translocation of the enzyme in association with increased phosphatidylcholine synthesis, however, is not a universal phenomenon [2, 3, 8] . In the fetal lung. although microsoma! cytidylyltransferase activity was reported to be increased by hormones in some studies [9] [10] [11] . the increases were generally found in the cytosol [9, [12] [13] [14] [15] [16] [17] , the fraction which also contained the bulk of the enzyme activity [9, 12, 18] .
In vitro cytosolic cytidylyitransferase activity can be increased by inclusion of lipids, such as phosphatidylglycerol [12, 191 or a mixture of oleic acid and phosphatidylcholine [20] , in the assay mixture. The st'.mulatory effects of glu~rtieoids 19, 15, 16, 21] , estrogen [12,131 and thyroid hormone [15] on cvtosolic cytidylyltransferase in fetal lung were diminished or abolished g,hen the assay was carried out in the presence of phosphatidylglyceroi. Such data strongly suggested that the hormones increased the catalytic activity rather than the amount of cytidylyltransferase pro'.ein. In other systems there was also evidence that the increase in cytidylyltransferase activity was due to enzyme activation rather than protein synthesis !1,6] . Direct proof of this concept, however, has been lacking, since the mass of cytidylyltransferase protein was not quantitated. With the development of procedures for purification of cytidylyltransferase [22, 23] it has become possible to develop antibodies and by immunotitration directly determine enzyme mass. Using that approach, we have now addressed the question of whether the glucocorticoid-induced increase in cytidylyltransferase activity in fetal rat lung is due to an increase in the amount of enzyme or to activation of existiug enzyme.
Timed pregnant Sprague-Dawley rats were purchased from Charles River Breeding Laboratories (Wilmingtor., MA). The day after mating was consider day 1; term in rat is day 22. On day 19 of gestation the dam was killed by decapitation and the fetuses were delivered by cesarean section under sterile conditions and weighed to confirm gestational age [24] . The lungs from all fetuses in each litter were combined to form a common pool of tissue from which explants (1 mm 3) were then prepared. The fetal lung explants were cultured for 48 h as described previously [25] in 2 ml of serum-free Waymouth's medium containing penicillin and streptomycin. The culture dishes were placed on a rocking platform (Bellco, Vineland, N J) so that at any one time half the explants were covered by the culture medium and the other half exposed to the atmosphere of 95% 02/5% CO 2. Dexamethasone (100 nM) was added to half of the dishes from each litter and the other half were used as controls. This concentration of dexamethasone has previously been shown to be more than sufficient to maximally stimulate the activity of cytidylyltransferase in 18-day fetal rat lung explants [91 with the maximum stimulation being achieved in approx. 20 h [21] . In the present study we used 19-day rather than 18-day fetuses to generate sufficient tissue so that one litter could be used in each experiment. In preliminary experiments the stimulatory effect of dexamethasone was essentially the same when explants of 19 day fetuses were cultured for only 24 h and when the hormone was added after 24 h as well as at the beginning of the 48 h culture period.
The medium was removed and the exp]ants washed twice with ice-cold 0.9% NaC1 and once with 330 mM sucrose/10 mM Tris-HCl/1 mM EDTA (pH 7.4). A 20% homogenate in the same buffer was prepared with a Potter-Elvehjem Teflon-glass homogenizer and centrifuged at 105000 x g for 1 h. Cytidylyltransferase was assayed in the supernatant fraction by measuring the rate of phospho[Me-laC]choline incorporation into CDPcholine as described by Gilfillan et al. [26] . Unless stated otherwise, 1.1 mM phosphatidylglycerol [26] or 0.2 mM phosphatidylcholine/0.2 mM oleic acid [22] were included in the assay mixture.
Cytidyitransferase from rat liver was purified as described previously [22] . Antiserum against the purified enzyme was raised in rabbits. The antiserum immunoprecipitated cytidylyltransferase activity in the cytosolic fraction of adult rat lung and liver. The IgG fraction isolated from the antiserum detected the 45000 Mr subunit of cytidyIyltransferase on Western blot analysis [27] . A detailed description of the antibody preparation and characterization will be subsequently published. To quantitate the amount of cytidylyltransferase in the fetal lung explants, antibody-antigen titrations were carried out using a fixed amount of antibody with variable amounts of 105 000 × g supernate [28] . The mixture of antiserum (2/~I) and antigen in a final volume of 315/~l of 10 mM Tris-HCl/1 mM EDTA/1.9 mM dithiothreitol (pH 7.4) was incubated at 4°C for 18 h. A 20% suspension of Protein A (50 /~l) was then added and after mixing several times over a 1 h period at 4°C the antibody-antigen complex was removed by centrifugation at 12000 x g for 10 rain. Cytidyltransferase activity was then assayed using 90 /~l of the supernatant. The units of enzyme activity (pmol/min) remaining after immunoprecipitation were plotted against the original
TABLE I
The effect of dexamethasone on the activity and amount of cytidylyltrt.nsferase in fetal rat lung explants Explants of 19-day fetal rat lung were cultured + 100 nM dexamethasone for 48 h after which cytidylyitransferase activity and equiva' nee points in the 105000× g supernatant fraction were measured. Cytidyly!transferase activity was measured ± 1.1 mM phosphatidylglyccrol (PG) in the assay mixture. Phosphatidylglycerol was included in the assay mixture when equivalence points were determined. The data are means:l= S.E. from four litters and were analyzed statistically with Student's t-test for paired samples.
Control
Dexametha The effect cf dexamethasone on the activity of cytidylyltransferase in fetal rat lung explants is shown in Table I . When a.ssayed without addition of phosphatidylglycerol to the reaction mixture, the hormone increased cytidylyltransferase activity by 87% (range: 57% to 14I %). This degree of stimulation was similar to that previously reported for explants of 18-day fetal rat lung [9.15,21] . As also reported previously [9, 15, 16, 21] , the stimulatory effect of dexamethasone was diminished when cytidylyltransferase activity was measured in the presence of phosphatidylglycerol (Table I) . Phosphatidylglycerol doubled the activity in the control group but only increased that in the dexamethasone-treated group by 58%. Thus the stimulatory effect of the hormone was reduced from 87% to 50% when thc assa2,' was carried out in the presence of phosphatidylglycerol. However, as the stimulator 3, effect of phosphatidylglycerol was variable, the dexamethasone-induced increase in cytidylyltransferase activity ranged from 6% to 83% in this assay condition. Fig. 1 shows that rabbit antiserum raised against rat liver cytidylyltransferase immunoprecipitated the en- fetal rat lung explants after which cytidylyltransferase was assayed in the presence of phosphatidylglycerol. The equivalence point, units of cytidylyltransferase (pmol/min) immunoprec~pitated, is the intercept on the abscissa when the inttial versus the final units of enzyme were plotted. These data are from one experiment, lniual cytidylyhrartsferase activities in the control and dexamethasone-treated expla.tts were 1123 and 2708 pmoi/min per mg protein when assayed without phosphatidylglycerol and were increased to 2392 and 438[3 pmol/rmn per mg protein when phosphatidytglyceroi ,*'as included in the assay.
zyme in the supematant fraction of type II cells which were isolated from 19-day fetal lungs as described by Viscardi et al. [11] . Serum from a control rabbit had no effect on cytidylyltransferase activity. A similar immunoprecipitation profile was obtained when the enzyme in control fetal rat lung explants was incubated with the antiserum. This antiserum was, therefore, used to quantitate the amount of cvtidylyitransferase in the control and dexamethasone-treated explants. In these experiments, cytidylyltransferase was assayed in the presence of phosphatid~Iglycerol, since the immunoprecipitation data were difficult to interpret when the assay was ca, tled out in its absence Although the stimulatory effect of the hormone was greater when the enzyme was assayed without addition of phospbatidyiglycerol, it is possible that the presence of inactive enzyme, which could be immunoprecipitated by the antibody, compromised the results. The result of an immunotitration using a fixed amount of antibody and variable amounts of supernate is shown in Fig. 2 . In that experiment, dexamethasone increased cytidylyltransferase activity, assayed in the presence of pbosphatidylglycerol, by 83% and increased the amotmt of activity inmaunoprecipitated by 107%. When the stimulator3, effect of the hormone on enzyme activity was less, its effect on the amount of activity immunoprecipitated was correspondingly less. As shown Table 1 . Cytidylyltransferase was assayed in the presence of phosphatidylglycerol. The regression coefficient (r = 0.996) is statistically significant (P < 0.005).
in Fig. 3 , there was a highly significant correlation between the de×amethasone-induced increase in cytidylyltransferase activity and enzyme units immunoprecipitated. As shown in Table I , the same amount of antibody removed 62% more units of enzyme from the treated group than the control and this increase was similar in magnitude to the 50% increase in cytidylyltransferase activity. Since the antibody should react with the same amount of protein in both the control and dexamethasone-trt.ated groups these data show that the hormone-induced increase in cytidylyltransferase activity is due to an increase in enzyme activity rather than mass. Glucocorticoids have long been known to accelerate lung maturation, stimulate surfactant production and increase lung phosphatidylcholine biosynthesis in the late gestation fetus [3] [4] [5] . Consistent with cytidylyltransferase being a regulatory enzyme in phosphatidylcholine biosynthesis [I,2] , glucocorticoids have been repot t~ , m .cease the activity of this enzyme in the fetal lung [2] . "1'.. stimulatory effect of the hormone was shown to be mediated by the glu~rticoid receptor and dependent on transcriptioL, and synthesis of new protein [91. The stimulatory effect o7 glu~rticoids on cytidylyltransferase activity could bt. ~,~nsiderably diminished when the enzyme activity was increased by inclusion of phosphatidylglyeerol in the assay ~.-rtixture [9, 15, 16] . These indirect data suggested tha~ the hormone-indueext increase in activity was due to activation of existing enzyme rather than synthesis of new enzyme protein. As at least some stimulation was still apparent [9, [15] [16] [17] even when the enzyme was assayed in the presence of sufficient phosphatidylglycerol to maximally activate the enzyme in vitro [12, 19, 26 ] the possibility of glucocorticoid induction of cytidylyltransferase synthesis remained. In the present study we' have now shown that the gluct-~orticoid-induced increase in cytidyl31transferase activity is not due to an increase in the amount of enzyme and must therefore be due to enzyme activation.
The increased cytidylyltransferase activity which accompanies increased phosphatidylcholine biosynthesis in other systems has also been attributed to enzyme activation rather than increased synthesis [1, 6] . However, because of difficulty in obtaining an antibody which immunoprecipitates cytidylyltransferase [30] , the mass of the enzyme has not generally been quantitated. To our knowledge there is only one previous study in which the mass of cytidylyltransferase was measured. In that study Choy et al. [31] generated a chicken antibody to rat liver cytidylyltransferase with which they showed that the amount of the enzyme was not decreased in association with decreased phosphatidylchofine synthesis in the livers of choline-deficient rats.
The finding that the activity but not the amount of cytidylyltransferase is increased by glucoeorticoids in fetal lung suggests two major questions. Firstly, how is cytidylyltransferase activity enhanced by the hormone? Secondly, since the stimulatory effect of the hormone on cytidylyltransferase activity [91 as well as on phosphatidylcholine biosynthesis [9, 32] is dependent on protein synthesis, which protein or proteins are induced? A number of mechanisms for activation of cytidylyltransferase have been proposed [1] and there is evidence that each of them can occur in the fetal lung. These include activation by dephosphorylation [33] , free fatty acids [181 and phospholipids [12, 19] as well as translocation from the cytosol to a membrane fraction of the cell [18] possibly promoted by one or more of the above activation mechanisms. The activity of fatty-acid synthase (EC 2.3.1.85) has been reported to be increased by glucocorticoids in fetal ra: [34, 35] and human [36] lung. There is evidence that this enzyme is induced by the hormone as both its activity and amount were increased [35] . We have also reported that inhibition of de novo fatty acid synthesis results in abolition of the stimulatory effect of dexamethasone on cytidylyltransferase activity in fetal rat lung explants [21] . A plausible hypothesis, therefore, is that glucoeorticoid induction of fatty-acid synthase results in increased synthesis of fatty acids which in tam, either d~rectly or after incorporation into phosphor pids, activate cytidylyltransferase [371.
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